IMMUNIC, INC. — Director's Dealing 2022

May 13, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2022-05-12

Reporting Person: Nash Duane (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-12	Common Stock	P	10000	$5.03	Acquired	22032	Direct
2022-05-12	Common Stock	G	6000	$0.00	Disposed	16032	Direct

Footnotes

F1: Represents a purchase of 10,000 shares.

F2: Represents a gift of 6,000 shares.